FormDSignal
47

Auron Therapeutics, Inc. raises $7.1M under Reg D

Company raise · Raising · WELLESLEY, MA · Form D filed 2026-08-13
$10M+ raise

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Briggs Duncan MorrisonDirector
Pini Duncan OrbachDirector
Serge Duncan MesserlianDirector
Victoria Duncan RichonDirector
Alexandra CantleyDirector
Anna Duncan FrenchDirector
Katharine YenExecutive Officer, Director

Signed by Katharine Yen, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer